Table 4.

Percentage of sites with clinical attachment loss ≤ 3 mm, 4-5 mm and ≥ 6 mm among well-controlled type 2 diabetes mellitus group, uncontrolled type 2 diabetes mellitus group without microvascular complications and uncontrolled type 2 diabetes mellitus group with microvascular complications

Variable, CAL	Group I (% of site)	Group II (% of site)	Group III (% of site)	P value a
CAL ≤ 3 mm	75.07	47.64	43.67	< 0.001
CAL 4-5 mm	22.16	37.53	38.43	< 0.001
CAL ≥ 6 mm	2.77	14.83	17.90	< 0.001

^a P < 0.001. A significant difference in percentage of sites with CAL ≤ 3 mm, 4-5 mm and ≥ 6 mm among well-controlled T2DM group, uncontrolled T2DM group without microvascular complications and uncontrolled T2DM group with microvascular complications. CAL: Clinical attachment loss; T2DM: Type 2 diabetes mellitus.